SHANGHAI, Feb. 24, 2016 /PRNewswire/ -- BioPh China 2016, hosted by UBM EMEA and China Chamber of Commerce of Medicines & Health Products Importers & Exporters and co-organized by UBM Sinoexpo, will be held on June 21-23, 2016 at Hall E2 in Shanghai New International Expo Centre.
The emerging industry of bio-medicine has become one of the strategic directions and focal development points of the pharmaceutical industry for the coming years. This focus is supported by a number of factors: recent completion of the Development of Pharmaceutical Industry for the Thirteenth Five-Year Plan Period in 2015, as well as by Made in China 2025 listing biomedicine represented by gene drugs, monoclonal antibody/protein drugs and vaccines as one of the ten key sectors to be develop in the future. The improvement of the overall technological content, the added economic value of the bio-medical industry, and fostering of innovative drugs are further contributing factors.
With biomedicine being one of the highlights of the Nobel Prize and Prix Galien Awards, the biomedical industry has undoubtedly entered another fast growing golden age. As an annual professional biopharmaceutical technology event highly anticipated in the Asia-Pacific region, BioPh China has received more focus from Europe and the U.S. in recent years.
BioPh China 2016 will provide a one-stop trade, exchange and learning platform for the biopharmaceutical industry and the latest biomedical R&D achievements and technologies.
Up to now, domestic pharmaceutical giants such as Gan & Lee Pharmaceuticals, Tonghua Dongbao, Shenzhen Mellow Hope and Dongcheng Biochemicals have all confirmed their participation at BioPh China 2016, showcasing the most advanced R&D achievements, technologies and solutions of biomedical technical fields, including protein, antigen, polypeptide, enzyme, bioprocessing, antibody, biological agent, bio-manufacturing, cell biology, clinical trial, new drug R&D, genomics, genetics, personalized medicine, stem cell research, therapeutics, vaccine, biofuel, nanotechnology, biological information, biological information technology, and platform technology.
To enhance the communication and cooperation between Chinese biomedical enterprises and international enterprises, the 3rd BioPh Summit China, as the most important concurrently held onsite event, will gather industry-university-research elites and leaders in the biomedical industry to discuss the course for future development of the industry.
The summit will focus on the recent dynamics of Chinese and foreign policies, global market opportunities and other strategic topics, as well as the latest Chinese and foreign research achievements in recombinant protein drugs, antibodies and vaccines, to provide industry practitioners with an excellent platform for sharing industry information, R&D experience and case analysis.
BioPh China 2016 will merge new thinking and concepts into the Chinese biomedical industry through linkage of "exhibition" and "conference". Online visitor registration is now open. For more information please visit http://www.cphi.com/china to register or contact:
SOURCE Shanghai UBM Sinoexpo International Exhibition Co., Ltd